WINTER SPRINGS, Fla.--(BUSINESS WIRE)--IRADIMED CORPORATION (NASDAQ:IRMD), the leading provider of non-magnetic intravenous (IV) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures, announced today the pricing of its initial public offering of 2,016,000 shares of its common stock at an initial public offering price of $6.25 per share for a total offering amount of $12.6 million before deducting underwriting discounts and commissions, and estimated offering expenses payable by Iradimed. In addition, the underwriters have been granted a 45-day option to purchase up to an additional 302,400 shares of common stock at the initial public offering price solely to cover over-allotments, if any. The shares are expected to begin trading on The NASDAQ Capital Market on July 16, 2014 under the symbol “IRMD.” The closing of the offering is expected to occur on July 21, 2014, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
